Therapix Biosciences Ltd.
TRPX
TRPX was delisted on the 1st of July, 2020.
4 hedge funds and large institutions have $8.47K invested in Therapix Biosciences Ltd. in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
68% less capital invested
Capital invested by funds: $26.5K → $8.47K (-$18K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$1.26K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$837 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$19.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $6K | -$19.9K | -7,865 | -77% |
|
|
2
UBS Group
Zurich,
Switzerland
| $1K | +$837 | +331 | New |
|
|
3
Wells Fargo
San Francisco,
California
| $1K | +$1.26K | +500 | New |
|
|
APA
4
American Portfolios Advisors
Holbrook,
New York
| $474 | – | – | – |
|
TRPX Hedge Fund Activity: Q3 2019 in Review
4 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Therapix Biosciences Ltd. (TRPX) for Q3 2019, worth a combined $8.47K — down 68% from $26.5K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TRPX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Wells Fargo, opening a new position worth an estimated $1.26K. The largest seller was Morgan Stanley, cutting an estimated $19.9K.
- 4 institutional investors held Therapix Biosciences Ltd. (TRPX) as of Q3 2019, up from 2 in Q2 2019.
- Funds reported $8.47K of Therapix Biosciences Ltd. stock for Q3 2019, down 68% quarter-over-quarter.
- 2 funds opened new Therapix Biosciences Ltd. positions in Q3 2019 and 0 closed out, a net change of +2 holders.
- The largest Therapix Biosciences Ltd. buyer in Q3 2019 was Wells Fargo, an estimated $1.26K added.
- The largest Therapix Biosciences Ltd. seller in Q3 2019 was Morgan Stanley, an estimated $19.9K sold.
Based on aggregated 13F filings for Q3 2019.